NEOS Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$108M Buy
117,395
+815
+0.7% +$826K 0.55% 33
2025
Q4
$125M Buy
116,580
+13,560
+13% +$13M 0.72% 18
2025
Q3
$78.6M Buy
103,020
+28,031
+37% +$20.9M 0.59% 25
2025
Q2
$58.5M Buy
74,989
+9,444
+14% +$7.34M 0.72% 20
2025
Q1
$54.1M Buy
65,545
+15,005
+30% +$12.5M 1.03% 14
2024
Q4
$39M Buy
50,540
+11,383
+29% +$9.43M 0.92% 14
2024
Q3
$34.7M Buy
39,157
+4,919
+14% +$4.42M 1.05% 13
2024
Q2
$31M Buy
34,238
+9,973
+41% +$7.98M 1.28% 11
2024
Q1
$18.9M Buy
24,265
+11,592
+91% +$8.25M 1.17% 11
2023
Q4
$7.39M Buy
12,673
+5,025
+66% +$2.93M 0.7% 26
2023
Q3
$4.11M Buy
+7,648
New +$3.94M 0.52% 39

Other funds holding LLY

NEOS Investment Management's LLY Position: Q1 2026 in Review

NEOS Investment Management increased its Eli Lilly (LLY) stake by 0.7% in Q1 2026, buying an estimated $826K and bringing the position to 117,395 shares worth $108M. The position accounts for 0.55% of the portfolio, ranked #33.

NEOS Investment Management first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $125M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • NEOS Investment Management held 117,395 shares of Eli Lilly worth $108M as of Q1 2026.
  • NEOS Investment Management bought 815 Eli Lilly shares in Q1 2026, an estimated $826K.
  • Eli Lilly made up 0.55% of NEOS Investment Management's portfolio in Q1 2026, its #33 holding.
  • NEOS Investment Management first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • NEOS Investment Management's Eli Lilly position peaked at $125M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.